| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 27 |
| 1 | INFLIXIMAB | 25 |
| 2 | CANAKINUMAB | 24 |
| 3 | COLCHICINE | 24 |
| 4 | MESALAMINE | 24 |
| 5 | TOCILIZUMAB | 24 |
| 6 | VEDOLIZUMAB | 24 |
| 7 | DEXAMETHASONE | 3 |
| 8 | DEXAMETHASONE 1.5 MG | 3 |
| 9 | HUMAN IMMUNOGLOBULIN G | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CANAKINUMAB | 24 | 0.0022 |
| 1 | COLCHICINE | 24 | 0.0009 |
| 2 | MESALAMINE | 24 | 0.0009 |
| 3 | VEDOLIZUMAB | 24 | 0.0003 |
| 4 | TOCILIZUMAB | 24 | 0.0002 |
| 5 | RITUXIMAB | 27 | 0.0001 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 7 | INFLIXIMAB | 25 | 0.0001 |
| 8 | HUMAN IMMUNOGLOBULIN G | 2 | 0.0001 |
| 9 | PIPERACILLIN AND TAZOBACTAM | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Alkaloid [EPC] | 24 | 0.0009 |
| 1 | Integrin Receptor Antagonist [EPC] | 24 | 0.0003 |
| 2 | Aminosalicylate [EPC] | 24 | 0.0002 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 24 | 0.0002 |
| 4 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 27 | 0.0001 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 26 | 0.0000 |
| 7 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Glycopeptide Antibacterial [EPC] | 1 | 0.0000 |
| 9 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |